Silence Therapeutics plc Increase (Decrease) in Other Current Assets
Silence Therapeutics plc (SLN) reported Increase (Decrease) in Other Current Assets of $1.40 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherCurrentAssets · last filed 2026-08-10
- Silence Therapeutics plc increase (decrease) in other current assets for the quarter ending 2026-06-30 was $2.33M.
- Silence Therapeutics plc increase (decrease) in other current assets for the quarter ending 2026-03-31 was -$931.00K, a 257.26% decline year-over-year.
- Silence Therapeutics plc increase (decrease) in other current assets for the quarter ending 2025-12-31 was $1.74M.
- Silence Therapeutics plc increase (decrease) in other current assets for the quarter ending 2025-09-30 was -$5.33M.
- Silence Therapeutics plc increase (decrease) in other current assets for fiscal 2025 was -$6.02M, a 552.33% decline from fiscal 2024.
- Silence Therapeutics plc increase (decrease) in other current assets for fiscal 2024 was $1.33M.
- Silence Therapeutics plc increase (decrease) in other current assets for fiscal 2023 was -$1.96M, a 137.60% decline from fiscal 2022.
- Silence Therapeutics plc increase (decrease) in other current assets for fiscal 2022 was $5.20M.
| Period end | Increase (Decrease) in Other Current Assets 3 month | Increase (Decrease) in Other Current Assets 6 month | Increase (Decrease) in Other Current Assets 9 month | Increase (Decrease) in Other Current Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.40M 10-Q · filed 2026-08-10 | $3.14M derived: sum of 3 quarters · filed 2026-08-10 | -$2.19M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$931.00K 10-Q · filed 2026-05-07 | $810.00K derived: sum of 2 quarters · filed 2026-05-07 | -$4.52M derived: sum of 3 quarters · filed 2026-05-07 | -$7.54M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $1.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$3.59M derived: sum of 2 quarters · filed 2026-03-05 | -$6.61M derived: sum of 3 quarters · filed 2026-08-10 | -$6.02M 10-K · filed 2026-03-05 |
| 2025-09-30 | -$5.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$8.35M derived: sum of 2 quarters · filed 2026-08-10 | -$7.76M 10-Q · filed 2025-11-06 | -$8.15M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | -$3.02M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$2.43M 10-Q · filed 2026-08-10 | -$2.82M derived: sum of 3 quarters · filed 2026-08-10 | -$3.73M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $592.00K 10-Q · filed 2026-05-07 | $200.00K derived: sum of 2 quarters · filed 2026-05-07 | -$717.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.15M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$1.31M derived: sum of 2 quarters · filed 2026-03-05 | $562.00K derived: sum of 3 quarters · filed 2026-03-05 | $1.33M 10-K · filed 2026-03-05 |
| 2024-09-30 | -$917.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $954.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.72M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $2.64M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $768.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | -$1.96M 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $5.20M 10-K · filed 2025-02-27 |